Sonoma Pharmaceuticals
SNOA
#10631
Rank
A$5.51 M
Marketcap
A$1.59
Share price
2.70%
Change (1 day)
-68.24%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -A$4.89 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$16.93 Million. In 2024 the company made an earning of -A$6.22 Million a decrease over its 2023 earnings that were of -A$6.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.89 Million-21.39%
2024 -A$6.22 Million0.54%
2023 -A$6.18 Million-31.5%
2022 -A$9.02 Million16.86%
2021 -A$7.72 Million194.32%
2020 -A$2.63 Million-58.76%
2019 -A$6.36 Million-65.66%
2018 -A$18.52 Million4.84%
2017 -A$17.67 Million-2.17%
2016 -A$18.06 Million32.12%
2015 -A$13.67 Million-307.74%
2014 A$6.57 M-197.5%
2013 -A$6.75 Million
2010 -A$10.55 Million-14.02%
2009 -A$12.27 Million-57.28%
2008 -A$28.7 Million-8.03%
2007 -A$31.21 Million3.85%
2006 -A$30.05 Million39.31%
2005 -A$21.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.27 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA